跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,556 条关于
“VERV-201”
全部
11,556
临床试验
5,859
药物
4,447
机构
20
资讯
1,230
18天前
ANGPTL3 Inhibitors Market Poised to Reach $3.48 Billion by 2035 as Pipeline Diversifies Beyond Monoclonal Antibodies
去年
Affinia Therapeutics Advances Novel Gene Therapy for BAG3 Dilated Cardiomyopathy with Promising Preclinical Results
去年
FDA Grants Breakthrough Therapy Designation to TSND-201 for PTSD Treatment
去年
QurAlis Advances ALS Programs: QRL-201 Enters Dose Range-Finding, QRL-101 Dosed in Phase 1
2年前
NXC-201 CAR T-cell Therapy Shows Promise in AL Amyloidosis Despite Mortality Concerns
去年
Absci Strengthens ABS-201 Hair Loss Program with Leading Dermatology Experts
3年前
Nexcella's NXC-201 Shows Promise in Relapsed/Refractory Multiple Myeloma and AL Amyloidosis
去年
Oncodesign Precision Medicine Reacquires OPM-201 Rights from Servier After Positive Phase I Trial
11个月前
Absci Accelerates ABS-201 Hair Loss Treatment Trial, Announces Expert Seminar for December
2年前
Minovia's MNV-201 Cell Therapy Shows Promise for Rare Pearson Syndrome Treatment
第 1 页,共 123 页
上一页
下一页